Asia Pacific: The immunology market in Asia Pacific, especially in China, Japan, and South Korea, is witnessing rapid growth owing to rising investments in healthcare infrastructure and growing patient population. Government initiatives to improve healthcare facilities and increase awareness about immunological disorders are also contributing to market growth in this region.
Europe: In Europe, countries such as the United Kingdom, Germany, and France are key markets for immunology products and services. The presence of well-established healthcare systems, high healthcare expenditure, and increasing prevalence of autoimmune diseases are fueling market growth in these countries. Additionally, collaborations between academic institutions and pharmaceutical companies are driving research and development activities in the field of immunology.